# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
CL King analyst Kristen Stewart initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of...
B of A Securities analyst Craig Bijou initiates coverage on Haemonetics (NYSE:HAE) with a Neutral rating and announces Price...
BTIG analyst Marie Thibault initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of $112.
Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Neutral and lowers the price target from $94 to $85.
JMP Securities analyst David Turkaly reiterates Haemonetics (NYSE:HAE) with a Market Outperform and maintains $125 price tar...